Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-02-13 BENZENO SHARON SVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-02-13 ZOLTNERS ANDRIS A Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 SANG CHARLES SVP, Clinical Diagnostics Grant or award · Stock Option (Right to Buy) +40,000 40,000
2020-02-13 BALDO LANCE Chief Medical Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2020-02-13 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-02-13 ROBINS CHAD M CEO and Chairman Sale −11,120 $31.56 $351K 1,878,180
2020-02-13 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 713,280
2020-02-13 ROBINS CHAD M CEO and Chairman Grant or award · Stock Option (Right to Buy) +300,000 300,000
2020-02-13 HILL NANCY LOUISE SVP, Operations Grant or award · Stock Option (Right to Buy) +50,000 50,000
2020-02-13 Conroy Kevin T Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 DOBMEIER ERIC Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-13 NEUPERT PETER M Director Grant or award · Stock Option (Right to Buy) +8,888 8,888
2020-02-12 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-02-12 ROBINS CHAD M CEO and Chairman Sale −11,120 $31.30 $348K 1,878,180
2020-02-12 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 724,000
2020-02-11 ROBINS CHAD M CEO and Chairman Option exercise +11,120 $0.33 $4K 1,889,300
2020-02-11 ROBINS CHAD M CEO and Chairman Sale −11,120 $31.18 $347K 1,878,180
2020-02-11 ROBINS CHAD M CEO and Chairman Option exercise · Stock Option (Right to Buy) −11,120 735,200
2020-02-10 Cohen Chad M Chief Financial Officer Option exercise +20,000 $4.07 $81K 21,000
2020-02-10 Cohen Chad M Chief Financial Officer Sale −3,279 $31.90 $105K 17,721

Page 113 of 120 · 2,386 trades